Unknown

Dataset Information

Bone remodeling and regulating biomarkers in women at the time of breast cancer diagnosis.


ABSTRACT:

Purpose

The majority of breast cancer patients receive endocrine therapy, including aromatase inhibitors known to cause increased bone resorption. Bone-related biomarkers at the time of breast cancer diagnosis may predict future risk of osteoporosis and fracture after endocrine therapy.

Methods

In a large population of 2,401 female breast cancer patients who later underwent endocrine therapy, we measured two bone remodeling biomarkers, TRAP5b and BAP, and two bone regulating biomarkers, RANKL and OPG, in serum samples collected at the time of breast cancer diagnosis. We analyzed these biomarkers and their ratios with patients' demographic, lifestyle, clinical tumor characteristics, as well as bone health history.

Results

The presence of bone metastases, prior bisphosp

SUBMITTER: Yao S 

PROVIDER: S-EPMC5243170 | biostudies-literature | 2017 Feb

REPOSITORIES: biostudies-literature